Freedom Isn’t Free!
Have you ever tried to register for an email or social networking account? Chances are your first few choices of usernames had already been taken up by someone else. Naturally, you would end up with silly usernames like “HunnyBunny” or “VinnyPeach”, which my colleagues have recently informed me, were slightly suggestive in nature. If I […]
Building Contractors In Patent Infringment Battle
A building contractor who asserted that it merely constructed buildings for the Malaysian Government according to technical drawings provided by JKR (the Public Works Department representing the Government of Malaysia) was held by the High Court to have: infringed Malaysian Patent No. MY114346-A granted to O-Stable Sdn Bhd (the patentee and the 1st Plaintiff) infringed the copyright […]
[Business Today] The Secret Powers of Trademarks and Brands
India Raises The Bar On Patentability Of Pharmaceuticals
In the much awaited decision of the Supreme Court of India in the case of Novartis AG vs. Union of India and others, the Supreme Court upheld the decision of the Indian Patent Office which refused to grant a patent on the beta crystalline form of the imatinib mesylatechemical compound, a therapeutic drug for chronic myeloid […]
[The Petri Dish] Gene Patenting: To patent or not to patent
“Handicapped” Protection For Descriptive Marks
The Singapore Court of Appeal (CA) was recently asked to decide on whether a descriptive mark could be protected against passing off if the descriptive elements of the mark were used by another party. The case was an appeal by the Singapore Professional Golfers’ Association (SPGA) against the decision of the High Court which found […]
[Business Today] Sensitive In Name
[Asia IP] Much Ado about Nutting: Nutella Vs. Nutello
[Business Today] Ignite Your Senses + Colour Wars
Amendments To Diovan Patent Claims Allowed
A recent decision in the High Court of Singapore involved yet another dispute in the pharmaceutical industry between an innovator giant and a generic manufacturer. This time, the case refers to a patent litigation battle between Switzerland-based Novartis and its exclusive licensee in Singapore (the Plaintiffs), and Ranbaxy (M) Sdn Bhd (the Defendant). On the […]